Zachary L Gitlin, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1 Hospital Rd, Oak Bluffs, MA 02557 Phone: 508-684-4500 Fax: 508-684-4502 |
Melanie A Miller, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Rd, Oak Bluffs, MA 02557 Phone: 505-684-4500 Fax: 508-684-4502 |
Karen Williams, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: Martha's Vineyard Hospital, 1 Hospital Road, Oak Bluffs, MA 02557 Phone: 508-693-3732 Fax: 508-790-6860 |
News Archive
A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland.
In a new study, Yale researchers offer insight into leptin, a hormone that plays a key role in appetite, overeating, and obesity. Their findings advance knowledge about leptin and weight gain, and also suggest a potential strategy for developing future weight-loss treatments, they said.
Oral mucositis is a frequent complication in patients taking mTOR inhibitors and a major reason for dose reductions and discontinuations in clinical trials, according to a review of this class of cancer drugs.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals have announced that a Supplemental New Drug Application (sNDA) for Nexavar (sorafenib) tablets has been submitted to the U.S. Food and Drug Administration (FDA) for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer. Nexavar is currently approved in more than 50 countries for the treatment of advanced kidney cancer.
› Verified 8 days ago